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Abstract
The anaphase promoting complex/cyclosome (APC/C) is a multi-subunit E3 ubiquitin ligase playing
essential functions in mitosis. It is conserved from yeast to human and relies on two adaptor
proteins, Cdc20 and Cdh1, to bring in substrates. Both APCCdc20 and APCCdh1 are implicated in the
control of mitosis through mediating ubiquitination and degradation of important mitotic regulators
such as cyclin B1, securin, and Plk1. In addition, APCCdh1 is thought to prevent premature S phase
entry by limiting the accumulation of mitotic cyclins in G1 and to regulate processes unrelated to
cell cycle. In this review, we will summarize our current understanding of APCCdh1 function in cell
cycle and beyond.
Introduction
Two ubiquitin E3-ligase complexes, SCF (Skp1/CUL1/F-
box protein) and APC/C (anaphase promoting complex/
cyclosome), control the timely transitions of cell cycle
phases by promoting the degradation of many key cell
cycle regulators. SCF complex mainly functions in G1, S
and early M phases, whereas APC/C regulates mitosis
including metaphase-anaphase transition and mitotic exit
and maintains G1 phase [1,2]. APC/C is a large (1.5 MDa
complex) composed of at lease 11 core subunits. It relies
on two WD-40 repeat-containing adaptor proteins,
Cdc20/fizzy(fzy)/p55CDC and Hct1/srw1/fizzy-
related(fzr)/Cdh1, to engage with its substrates. Destruc-
tion box (RXXLXXXXN/D/E) and KEN box are motifs fre-
quently found in APC's substrates, but other motifs are
also possible for recognition by APCCdc20 or APCCdh1 [3].
The consensus sequence of destruction box can be found
in many proteins. However, not all of these proteins are
APC's substrates. Thus, there must be other sequence con-
strains we do not understand yet that define true APC sub-
strates. Moreover, some substrates only have an RxxL
motif and yet are recognized by APC, indicating the last
amino acid in the consensus is not stringently conserved.
APCCdc20  initiates the metaphase-anaphase transition
through mediating the ubiquitination and degradation of
cyclin B1 and securin. To prevent premature separation of
sister chromatids and mitotic exit, APCCdc20 is inhibited by
Mad2 and BubR1 through the spindle assembly check-
point mechanism [4-9]. Only when the sister chromatids
are aligned at the metaphase plate and have established
bivalent spindle attachment can the inhibition of APC/
Cdc20 be released. In contrast to APCCdc20, APCCdh1 is
inactive in early mitosis [3] when it is inhibited by phos-
phorylation [10] and binding of Nup90/Rae1 complex
[11,12]. APCCdh1 only becomes active from late mitosis to
G1. The difference in the timing of activation between
APCCdc20  and APCCdh1  suggests a functional division
between the two E3 ubiquitin ligases in mitosis. Recent
analyses of mice deficient in Cdc20 or Cdh1 strongly sup-
port that notion [13-15]. It appears that Cdc20 is required
for metaphase to anaphase transition [15], whereas Cdh1
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plays a nonessential role in mitotic exit but an essential
role in G1/S regulation [13,14].
Mitotic Function of Cdh1
A large number of mitotic regulators are degraded at the
end of mitosis. These include Cdc20, Aurora B, Plk1, etc.
and are most likely the substrates of APCCdh1 (Table 1)
[16-43]. Although many of these mitotic regulators did
accumulate in the absence of Cdh1, they were eventually
degraded, probably because of the stabilization of Cdc20
that compensates for the loss of Cdh1 [13,14]. As a result,
Cdh1-deficient cells could still proliferate. However, these
cells did accumulate mitotic errors and display difficulties
in completing cytokinesis, resulting in the formation of
binucleated cells at a high frequency [13,14].
The lethality associated with the loss of Cdh1 is largely a
result of failed development of placenta, an essential
organ for embryonic life in mammals [13,14]. In the pla-
centa, there is a special cell type, giant cells which are poly-
ploid. The polyploidy is acquired through
endoreplication. In the absence of Cdh1, the placental
giant cells failed to form, suggesting that APCCdh1  is
required for DNA endoreplication. To undergo endorepli-
cation, a cell must not enter mitosis after a round of DNA
synthesis. One critical factor for mitotic entry is cyclin B1,
a substrate of APCCdh1 [33]. Therefore, it is possible that
the failed formation of giant cells in Cdh1 mutant
embryos was a result of the inability of the would-be giant
cells to block the accumulation of cyclin B1. Indeed, cyc-
lin B1 was readily detectable in the mutant placenta in the
area where the giant cells should reside [14].
Like an endoreplicating cell, cells with their DNA dam-
aged do not enter mitosis either. A recent study revealed
that APCCdh1-medicated degradation of Plk1 played an
important role in preventing mitotic entry of DNA-dam-
aged cells [44]. Under normal conditions, Cdh1 is kept
inactive from late G1 to early mitosis. When cells suffered
DNA damage, Cdc14B is translocated out of nucleoli into
nuclearplasm where the phosphatase dephophorylates
and activates Cdh1 [44]. It is unknown if a similar mech-
anism is employed by the placental giant cells to activate
Cdh1 in G2 to prevent mitotic entry.
Maintenance of G1 by APCCdh1
In Drosophila, loss of fzr leads to an extra division cycle in
the epidermis, a likely result of the accumulation of
mitotic cyclins in G1 [45]. In HeLa cells, knocking down
the expression of Cdh1 causes stabilization of Skp2
[46,47], a F-box containing protein responsible for bring-
ing p27Kip1 to the SCF complex for ubiquitination [48,49].
As a result, p27 is destabilized in the cells with impaired
Cdh1 function and the G1 phase is shortened in these
cells.
Our recent work identified Ets2 as a new substrate of
APCCdh1 [14]. Ets2 is a member of the Ets family of tran-
scription factors which share a unique DNA binding
domain, the ETS domain [50,51]. The first Ets protein was
identified as transduced mutant form of Ets1, v-Ets, in a
retrovirus, E26 (ETwenty six-specific, so the name Ets)
avian leukosis virus (ALV), that induces erythroblastosis
in avian species [52]. It is well known that Ets2 is activated
by Ras-Raf-MAPK signaling and mediates some effects of
this important signaling pathway [53-59]. The most
prominent effect of Ras signaling is the stimulation of pro-
liferation which relies in part on the induction of cyclin
D1 expression by Est2 [60,61]. Increased expression of
Ets2 has been associated with initiation and progression
of various cancer types [62-65] and its expression was
altered in cervical cancer cell lines due to chromosomal
changes in 21q22.1–22.2 where human ETS2 resides [66].
Moreover, Ets2 was found overexpressed in esophageal
squamous cell carcinoma [67]. These results suggest that
Ets2 is an oncogene. By targeting both Skp2 and Ets2,
APCCdh1 maintains G1 by increasing the levels of a Cdk
inhibitor p27 through destabilizing Skp2 and by limiting
the expression of cyclin D1 through promoting Ets2 deg-
radation (Fig. 1). Since both Skp2 and Ets2 are potential
oncogenes, APCCdh1  may possess tumor-suppression
activity. Indeed, mice heterozygous for Cdh1 display
increased rates of tumorigenesis at old ages [13].
It was shown previously by Nasmyth's group that inacti-
vation of APC/C by deleting its subunit APC2 in adult
hepatocytes induced these otherwise quiescent cells to re-
enter cell cycle [68]. This is most likely a result of the loss
Table 1: Substrates of APCCdh1.
Substrates Function Reference
Cdc20 anaphase onset [16,17]
Securin anaphase onset [18,19]
Sgo1 anaphase onset [20]
Rcs1 anaphase onset [21]
XKid spindle assembly [22,23]
Tpx2 spindle assembly [24]
Ase1 spindle assembly [25,26]
Aurora A mitotic exit [27,28]
Aurora B mitotic exit [29]
Plk1 mitotic exit [30]
Anillin mitotic exit [31]
CKAP2 mitotic exit [32]
Cyclin B1 mitotic exit [33]
Cyclin A mitotic exit [34]
Cdc6 DNA synthesis [35-37]
Geminin DNA synthesis [38,39]
FoxM1 G1/G0 maintenance [40,41]
SnoN Tgf-β signaling [42,43]
Ets2 Ras signaling [77]
Id2 transcription [86]Cell Division 2009, 4:2 http://www.celldiv.com/content/4/1/2
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of APCCdh1 activity and subsequent accumulation of Skp2
and Ets2.
To enter S-phase, APCCdh1 must be inactivated. Several dif-
ferent mechanisms are in place to contain APCCdh1
[69,70]. First, the ubiquitination of APC-specific
ubiqutin-conjugating enzyme (E2) UbcH10 by APCCdh1
itself provides a negative feedback mechanism that would
eventually destroy APCCdh1 activity [71,72]. Second, as
Cdk activity accumulates, Cdh1 is phosphorylated. The
phosphorylation promotes Cdh1 dissociation from APC
[10,73]. Third, phosphorylated Cdh1 is targeted by SCF
liagse [74], further limiting the activity of APCCdh1.
Finally, in late G1 phase, E2F activates the transcription of
early mitotic inhibitor-1 (Emi1)/Rca1, which inhibits the
activity of APC/CCdh1 as a pseudo-substrate [75,76].
Cdh1 and Cellular Senescence
Opposite to the expected high proliferation rates in Cdh1-
deficient cells, Cdh1-/-  mouse embryonic fibroblasts
(MEFs) proliferate poorly and entered senescence after
only a few passages [77]. We found that the induction of
p16Ink4a in these cells was the cause for the reduced prolif-
eration potential. The reason for the increased levels of
p16 in Cdh1-/- MEFs could simply be that p16 is a sub-
strate of APCCdh1. Alternatively, it could be that a tran-
scriptional activator of p16 is a substrate. It turned out
that the latter was the case [14]. We demonstrated that
Cdh1-deficiency induced upregulation of p16 was a result
of Ets2 stabilization. It was shown previously that Est2
could activate p16 expression [78]. The expression of p16
is regulated by a number of factors in response to various
stimuli. Under normal conditions, Ets2 levels are not
enough to induce p16 expression and senescence because
of Id1 and Bim1 (Fig. 2A). Id1 interacts with Ets2 and
blocks its transcriptional activation of p16 [78,79],
whereas Bmi1 directly represses p16 promoter [80]. Our
identification of the APCCdh1-Ets2-p16 axis shows the del-
icacy of the balance that determines the level of p16
expression. Loss of Cdh1 leads to increases in the levels of
Ets2 to the point that it overcomes Id1's inhibition and
results in senescence (Fig. 2B). This would imply that Ets2
activity required for p16 activation and that for other tar-
gets are different, which remains to be determined.
Overactivation of Ras signaling could also cause senes-
cence in primary cells [81-83]. It is likely that Ets2 medi-
ates, at least in part, this senescence effect of Ras signaling
(Fig. 2C). It remains to be determined however if Ras sig-
naling interacts with APCCdh1. The phosphorylation of
Ets2 by Erk may interfere with the recognition of Ets2 by
Cdh1, for example, leading to stabilization of Est2. There-
fore, when Ras signaling is overactivated, APCCdh1 would
only be able to provide limited balancing function against
Ets2. By placing p16 under the transcriptional control of
Ets2, evolution has setup a failsafe mechanism to prevent
unwarranted proliferation.
Cdh1 and Neural Function
Two places where appreciable levels of Cdh1 (and APC
subunits) but not Cdc20 are expressed in adult mice are
the brain and the liver [84]. In the liver, APCCdh1 is likely
required for preventing hepatocytes from reentering the
cell cycle spontaneously (see above). What is the function
of APCCdh1  in postmitotic neurons? The depletion of
Cdh1 expression in primary neuron of the cerebellar cor-
tex promotes significant elongations of axons, indicating
a role of APCdh1 in limiting axonal growth [85], possibly
through regulating the abundance of SnoN and Id2
[86,87]. APCCdh1  may also control pattering of axon
growth in the mammalian brain [85].
We assessed neural functioning of mice that are hetero-
zygous Cdh1 mutant. Electrophysiology studies of hip-
pocampus revealed a deficit in late phase long-term
potentiation (L-LTP), a process that underlies synaptic
plasticity and is known to depend on both protein synthe-
sis and degradation [88]. In behavior tests, we found that
Cdh1 heterozygous mice performed poorly in contextual
fear conditioning [14], a hippocampus-dependent proc-
ess [89,90], but no difference was observed in cued fear
condition which is less dependent on hippocampus
[89,90]. Similar behavior findings were also reported by
Cdh1 regulate the timing of S-phase entry Figure 1
Cdh1 regulate the timing of S-phase entry.
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Malumbres' group [13]. It is unclear at the moment what
are the substrates of APCCdh1 that play a role in memory
formation in mammals. However, studies from lower
organisms may provide a clue. In C. elegans, the abun-
dance of GLR-1 glutamate receptors in the ventral nerve
cord is regulated by anaphase promoting complex, albeit
unlikely to be in a direct manner [91]. In Drosophila,
Liprin-α, a multidomain scaffolding protein which is
localized to synapses and regulates synaptic activities,
seems to be a substrate of APCCdh1 [92]. It remains to be
determined if mammalian homologues of Liprin-α and
GLR-1 are regulated by APCCdh1 and if their misregulation
can account for the learning and memory defects dis-
played by Cdh1 heterozygous mice.
Conclusion
Tremendous progresses have been made towards under-
standing the regulation and function of APC/C in the last
decade. Its role in cell cycle regulation has largely been
elucidated. It appears that APCCdc20 is dedicated to mitosis
while APCCdh1  has a much broader application not
restricted to the cell cycle. The most intriguing question
remains to be addressed is the role of APC/C in non-divid-
ing cells. Accumulating evidence points to the involve-
ment of APCCdh1  in many aspects of neural function
including axon growth, morphology and plasticity of syn-
apses, and learning and memory. Identification of the rel-
evant substrates will provide significant insights into the
functioning of the complex nervous system. Further, in
addition to its potential role in maintaining the G0 state
of hepatocytes, whether APCCdh1 participates in the phys-
iological function of the liver remains to be elucidated
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